Surgical Robots Segment to Grow Significantly During 2022-2028

Based on product, the medical robots market has been segmented into surgical robots, hospital & pharmacy robots, rehabilitation robots, non-invasive radiosurgery robots, and others. Robotic surgeries are surgical procedures done by using the robotic surgical system. Surgical robots are self-automated and computer-controlled medical devices programmed to assist in the positioning and manipulating the surgical instruments. These surgical robots help surgeons to perform complex surgical procedures. These robots are not meant to perform surgery independently. These are operated by surgeons. Surgical robots enhance the capabilities of surgeons performing open surgeries. They provide more precision and control during the procedure. Therefore, surgical robots are allowed to perform complex and advanced surgical procedures with increased precision in minimally invasive ways. The surgical robots segment is expected to be valued at US$ 3,393.89 million in 2022. It is estimated to grow at a CAGR of 18.1% during the forecast period from 2022 to 2028 to reach US$ 9,188.29 million by 2028.

The surgical robots segment is further sub segmented into neurological surgery robotic systems, cardiology surgery robotic systems, laparoscopic surgical robotic systems, orthopedic surgical robotic systems, and steerable robotics. Among the listed surgical robotic systems, the neurological surgical robotic systems segment is the fastest-growing sub-segment.

COVID-19 Pandemic Impact on Medical Robots Market

After the onset of the COVID-19 pandemic, the global healthcare systems have been severely challenged with an explosive surge of positive cases, resulting in a significant increase in the demand for medical care.

Increased need for treatment and solution for Coronavirus increased demand for management of COVID-19 cases in hospitals and other healthcare facilities. The global impacts of COVID-19 are being felt across several markets. Although the healthcare sector had witnessed SARS, H1N1, and other outbreaks in the last few years, the severity of the COVID-19 has made the situation more complicated due to its mode of transmission. North America has been witnessing growing number of COVID-19 cases since its outbreak.

As a result, health care systems are overburdened, and the delivery of medical care to all patients has become a challenge in the region. In addition, medical device industry is also facing negative impact of this pandemic. As the COVID-19 pandemic continues to unfold, medical device companies are finding difficulties in managing their operations. Many companies offering medical robots have their business operations in the globe and business are adversely being affected by the effects of a widespread outbreak of COVID-19. This has disrupted and restricted company's ability to distribute products, as well as temporary closures of company's facilities. However, gradually hospitals have started resuming elective procedures as the COVID-19 recovery rate is increasing the demand for medical equipment like medical robots is expected to increase.

The medical robots market majorly consists of players such as Intuitive Surgical, Inc.; Stryker; Hocomo AG; Medtronic; Auris Health Inc.; Accuray; Omnicell Inc.; ARxIUM; and Ekso Bionis.

The report segments the medical robots market as follows:

The medical robots market is segmented based on product, application, and end user. Based on product, the medical robots market is segmented into surgical robots, hospital & pharmacy robots, rehabilitation robots, non-invasive radiosurgery robots, and others. Based on application, the medical robots market is segregated into laparoscopy, neurology, orthopedics, gynecology, urology, cardiology, and others. Based on end user, the medical robots market is segmented into hospitals, ambulatory surgical centers, and others.

By geography, the global medical robots market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com